genes for P2Y receptors (P2Y1, 2, 4, 6, 11-14R) . Several purinoceptors have been reported to be expressed in microglial cells [14, 15] . These include P2X4R, P2X7R, P2Y6R and P2Y12R. P2Y12R, which couples to Gi signalling in microglia, is implicated in ATPinduced membrane ruffling and chemotaxis towards a source of ATP [7, [16] [17] [18] [19] . Activating P2Y6R, which is up-regulated in activated microglia following neuronal injury, induces phagocytosis of damaged neurons through the Gq/phospholipase C/IP3 pathway [8] . We have shown that P2X4R is up-regulated in activated microglia in the spinal cord after peripheral nerve injury [20] . Stimulation of P2X4R in microglia leads to a release of brainderived neurotrophic factor (BDNF) [21, 22] , which is implicated in neuropathic pain, a debilitating pain condition that occurs after nerve damage [21, 22] . Furthermore, there is evidence that upregulation of P2X4R expression in activated microglia is found in a model of stroke [23] , brain tumour [24] , traumatic brain injury [25, 26] , spinal cord injury [27] and human acute inflammatory demyelinating polyradiculoneuropathy [28] . Despite rapidly accumulating evidence that the up-regulation of P2X4R in microglia might be an important process in the pathogenesis of CNS disorders, including neuropathic pain [10, 13, 21, 22] , the molecular mechanism underlying P2X4R up-regulation in microglia remains unknown.
We have recently demonstrated that fibronectin, an extracellular matrix protein, is a factor that up-regulates P2X4R expression at both mRNA and protein levels in primary cultured microglia in vitro [29] . The level of fibronectin is increased in the spinal cord after nerve injury, and blocking integrins in vitro and in vivo attenuates the augmentation of P2X4R expression and neuropathic pain behaviour [30] . We [31] . However 
have recently shown that the up-regulation of P2X4R gene expression in response to fibronectin is suppressed by PP2, an inhibitor of Src-family kinases (SFKs), and is not observed in microglial cells from mice lacking Lyn, a member of the SFKs, implying that Lyn tyrosine kinase in microglia is a key molecule in the signalling pathway that causes the up-regulation of P2X4R expression by fibronectin

Materials and methods
Microglial cells
Rat primary cultured microglia were prepared according to the method described previously [20, 32] [31, 33] , LY294002 (2 M; Tocris, Bristol, UK) [33, 34] , U0126 (10 M; Tocris) [33, 35] , pifithrin-␣ (10 M; Biomol, PA) [36, 37] , MG-132 (5 M; Calbiochem) [38, 39] and CGP57380 (30 M; Calbiochem) [40, 41] were pre-incubated with microglial cells for 1 hr before plating. Nutlin-3 (10 M; Calbiochem) [42, 43] 
Semi-quantitative RT-PCR
GAGCTCCCTCTGAGTC-3Ј (forward) and 5Ј-CTTCGGGTAGCTGGAGTGAG-3Ј (reverse). All values were normalized with the ␤-actin expression. The forward and reverse primer pairs for ␤-actin were 5Ј-AGGGAAATCGT-GCGTGACAT-3Ј (forward) and 5Ј-TCCTGCTTGCTGATCCACAT-3Ј (reverse).
Statistical analyses
Statistical analyses of the results were evaluated using the Tukey's multiple comparison test after one-way ANOVA.
Results
Distinct roles of PI3K-Akt and MEK-ERK signalling pathways in fibronectin-induced up-regulation of P2X 4 R expression
Our previous study has shown that fibronectin increases the expression of P2X4R protein in microglia via Lyn kinase [31] . [45] [46] [47] . Fig. 2A Fig. 4A , we found that nutlin-3 abolished both the fibronectin-induced decrease in p53 protein and the subsequent increase in P2X4R expression (Fig. 4B) [51] . As shown in Fig. 5A (Fig. 6B) 0.05, Fig. 6A ). The level of phosphorylated MNK1 in response to fibronectin was abolished in microglia pre-treated either with PP2 or U0126 but not with LY294002 (Fig. 6B) . To explore the functional relevance of MNK1-eIF4E signalling, we pre-treated microglia with CGP57380 and found that the fibronectin-induced P2X4R up-regulation was significantly attenuated by CGP57380 (P Ͻ 0.05, Fig. 6C) . Therefore, the MEK-ERK signalling pathway controls P2X4R expression through activation of the translational factor eIF4E.
Signalling via Lyn and other SFKs plays a role in fibronectin-stimulated PI3K and ERK activation
expression was attenuated in the presence of either PP2 (P Ͻ 0.01) or LY294002 (P Ͻ 0.01) but was not attenuated by U0126 (Fig. 3B). Because p53 degradation via the proteasome involves mouse double minute 2 (MDM2), an E3-ubiquitin ligase that binds to p53 [50], we tested the effect of nutlin-3, a novel small-molecule inhibitor of MDM2. As shown in
Activation of a translational factor through the MEK-ERK pathway regulates P2X 4 R expression
Based on our findings that inhibiting MEK-ERK signalling suppresses P2X4R protein levels without changing P2X4R mRNA levels, we investigated the role of this signalling in post-transcriptional regulation, focussing on the eukaryotic translation initiation factor 4E (eIF4E), which is a key protein in the translation-initiation process and requires signalling through the MEK-ERK pathway for its activation
, implying an involvement of MEK-ERK signalling. Consistent with evidence that MAPK-interacting protein kinase-1 (MNK1) is a serine/threonine kinase that phosphorylates eIF4E [52], the fibronectin-induced phosphorylation of eIF4E was inhibited by the specific inhibitor of MNK1, CGP57380 (P Ͻ
In addition, in the present study, we used primary cultured microglial cells isolated at 9-10, 14-15 and 22-24 [53, 54] . We found that the p53 inhibitor pifithrin-␣ caused increases in levels of P2X4R transcripts and protein. Although pifithrin-␣ has been reported to also show p53-independent effects (such as MAPK inhibition) [55, 56] The results of this study provide another important mechanism by which fibronectin promotes P2X4R expression in microglia: a post-transcriptional regulation through MEK-ERK signalling. There is evidence that ERK is crucial for post-transcriptional events, such as transport of nucleocytoplasmic RNA [62] and RNA translation [63] . In the present study, we demonstrated that MEK-ERK signalling induced phosphorylation (at serine 209) of the translational factor eIF4E. eIF4E is a phosphoprotein that binds to the cap structure at the 5'-end of cytoplasmic mRNA and acts to promote mRNA translation with an interaction with eIF4G, a molecule that binds to other translation factors, including eIF4A and eIF3 [51] . Phosphorylation of eIF4E increases its affinity for the 5'-cap4 and facilitates its incorporation into eIF4F complexes, suggesting an increase in translational efficiency [64] . It has been shown that ERK can increase phosphorylation of eIF4E via MNK1 [51, 65] [51, 66, 67] .
Fig. 5 Fibronectin activates eIF4E via ERK. (A) Time course of eIF4E phosphorylation (p-eIF4E) after fibronectin stimulation (FN; 10 g/ml) in primary cultured microglia. Equal amounts of protein loaded on each lane were verified by the band intensity of ␤-actin. (B) Effects of kinase inhibitors on fibronectin-induced phosphorylation
In summary, we propose the following molecular machinery for the up-regulation of P2X4R expression in microglia in response to fibronectin (Fig. 7) [10, 13, [20] [21] [22] , mice lacking Lyn tyrosine kinase exhibit impaired pain behaviour and attenuated P2X4R upregulation in microglia after nerve injury [31] . Inhibitors of PI3K-Akt signalling and of the proteasome have been reported to attenuate neuropathic pain [68, 69] . Furthermore, ERK activation occurs in microglia after nerve injury, and inhibiting the activation suppresses nerve injury-induced pain [70] . Interestingly, ERK activation in microglia is observed from 2 to 10 days after nerve injury [70] , which is similar to the time course of fibronectin upregulation in the spinal cord, which contributes to initiation of P2X4R expression in microglia [29, 30] 
